Asensus Surgical, Inc.
ASXC · AMEX
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $2,207 | $1,123 | $5,431 | $1,089 |
| % Growth | 96.5% | -79.3% | 398.7% | – |
| Cost of Goods Sold | $2,769 | $3,170 | $4,378 | $2,869 |
| Gross Profit | -$562 | -$2,047 | $1,053 | -$1,780 |
| % Margin | -25.5% | -182.3% | 19.4% | -163.5% |
| R&D Expenses | $7,631 | $8,091 | $8,614 | $9,290 |
| G&A Expenses | $5,994 | $4,374 | $3,992 | $4,571 |
| SG&A Expenses | $9,649 | $8,016 | $7,773 | $8,709 |
| Sales & Mktg Exp. | $3,655 | $3,642 | $3,781 | $4,138 |
| Other Operating Expenses | $110 | $114 | $113 | $114 |
| Operating Expenses | $17,280 | $16,107 | $16,387 | $17,999 |
| Operating Income | -$23,542 | -$18,154 | -$15,998 | -$19,779 |
| % Margin | -1,066.7% | -1,616.6% | -294.6% | -1,816.3% |
| Other Income/Exp. Net | -$4,791 | -$4,297 | -$1,723 | $1,518 |
| Pre-Tax Income | -$25,674 | -$22,451 | -$17,057 | -$18,261 |
| Tax Expense | $75 | $46 | $178 | $57 |
| Net Income | -$25,749 | -$22,497 | -$17,235 | -$18,318 |
| % Margin | -1,166.7% | -2,003.3% | -317.3% | -1,682.1% |
| EPS | -0.095 | -0.08 | -0.065 | -0.072 |
| % Growth | -18.3% | -22.7% | 8.8% | – |
| EPS Diluted | -0.095 | -0.08 | -0.065 | -0.072 |
| Weighted Avg Shares Out | 272,316 | 269,265 | 264,348 | 256,184 |
| Weighted Avg Shares Out Dil | 272,316 | 269,265 | 264,348 | 256,184 |
| Supplemental Information | – | – | – | – |
| Interest Income | $66 | $126 | $277 | $406 |
| Interest Expense | $321 | $0 | $0 | $0 |
| Depreciation & Amortization | $951 | $955 | $984 | $867 |
| EBITDA | -$24,402 | -$17,199 | -$16,073 | -$17,394 |
| % Margin | -1,105.7% | -1,531.5% | -295.9% | -1,597.2% |